View Document Preview and Link Document Date: 2003-01-14 17:33:38 Open Document File Size: 80,46 KB Share Result on Facebook
City York / Houston / Kenilworth / Denver / Geneva / New York / / Company Ishak KG / Goldman / Stephens / Schering Plough Inc. / / Country United States / / Currency USD / pence / / / Facility The University of Texas M. D. Anderson Cancer Center / University of Maryland / / IndustryTerm magnetic resonance imaging / transportation difficulties / treatment protocol / Cancer Treatment / aggressive surgical management / liver protocol / / MedicalCondition palmar erythema / Neoplasms / human renal carcinoma / tumor TP / also later experienced disease / advanced colorectal cancer / islet cell tumors / HBV / advanced cirrhosis / cirrhosis / stomatitis / brain metastasis / hepatitis B / Metastatic disease / either hepatitis B / Liver cirrhosis / metastatic carcinoid / diarrhea / stage IIIA disease / radiologically measurable tumor / Interferon-induced tumor TP upregulation18 / tumor / Cancer / tumors / hepatocellular carcinoma / malignant endocrine pancreatic tumours / stage IVB disease / human cancer / neutropenia / hepatic encephalopathy / adequate tumor / HCV / PR later experienced disease / vomiting / HCV infection / virus infection / portal hypertension / greater stomatitis / vascular tumor / multilobar disease / stable disease / IIIB disease / increased tumor / advanced colorectal carcinoma / infection / viral hepatitis / chronic infection / HCV RNA / disease progression / primary liver cancer / chronic active hepatitis C / colorectal cancer / primary hepatobiliary cancers / leukopenia / metastasis / nausea / Tumor Node Metastasis staging Stage IIIA Stage IIIB Stage IVA Stage IVB Hepatitis virus status Hepatitis B / thrombocytopenia / hepatitis C / J Cancer / infantile hemangiomas / small tumors / Liver tumors / fatigue / abundant fibrosis / spider angioma / inoperable hepatocellular carcinoma / human bladder carcinoma / fibrolamellar hepatocellular carcinoma / lung metastases / pancreatic cancer / Primary hepatocellular cancer / disease / IV disease / stage IIIB disease / progressive disease / tumour / advanced carcinoma / mucositis / fibrolamellar carcinoma / liver and extrahepatic disease / diabetes mellitus / advanced carcinoid / hand-foot syndrome / esophageal varices / hepatic cirrhosis / anemia / chronic hepatitis C / tumor thrombus / / MedicalTreatment biologic therapy / radiotherapy / surgery / Induction of remission / Non-surgical treatment / combination chemotherapy / Chemoprevention / chemotherapy / treatment protocol / / MusicGroup Grade / Nausea / / Organization Greenebaum Cancer Center / World Health Organization / University of Maryland / American Society of Clinical Oncology / Division of Pharmacy / MR NC PD / University of Texas M. D. Anderson Cancer Center / Department of Surgical Oncology / HCC / American Joint Committee on Cancer / Department of Gastrointestinal Medical Oncology and Digestive Diseases / Stat Assoc / / Person Richard D. Lozano / J. Nicolas Vauthey / Ann Oncol / M. Ellis Purpose / Steven A. Curley / Z. Patt / Arch Allergy / Lee M. Ellis / Arch Intern / Thomas D. Brown / Manal M. Hassan / / / Position VP / Greenlee RT / El Serag HB / / Product cisplatin / SC / platinol / spironolactone / Fluorouracil / furosemide / / ProvinceOrState New York / South Carolina / New Jersey / South Dakota / / PublishedMedium Journal of Clinical Oncology / / Technology treatment protocol / apoptosis / magnetic resonance imaging / gene expression / chemotherapy / alpha / tomography / antibodies / cloning / transplantation / MRI / three-phase liver protocol / Biomodulation / / SocialTag 
Phase II Trial of Systemic Continuous Fluorouracil and Subcutaneous Recombinant Interferon Alfa-2b for Treatment of Hepatocellular Carcinoma